Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux in CABG
NCT00474591Phase 3Unknown
- Sponsor
- Hamilton Health Sciences
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of fondaparinux in Coronary artery bypass graft failure, sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
fondaparinux
03
Conditions
Coronary artery bypass graft failure
Beyond the preview
Go deeper on NCT00474591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474591.